Your browser doesn't support javascript.
loading
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary.
Bajorin, Dean F; Witjes, J Alfred; Gschwend, Jürgen E; Schenker, Michael; Valderrama, Begoña P; Tomita, Yoshihiko; Bamias, Aristotelis; Lebret, Thierry; Shariat, Shahrokh F; Park, Se Hoon; Ye, Dingwei; Agerbaek, Mads; Enting, Deborah; McDermott, Ray; Gajate, Pablo; Peer, Avivit; Milowsky, Matthew I; Nosov, Alexander; Antonio, João Neif; Tupikowski, Krzysztof; Toms, Laurence; Fischer, Bruce S; Qureshi, Anila; Collette, Sandra; Unsal-Kacmaz, Keziban; Broughton, Edward; Zardavas, Dimitrios; Koon, Henry B; Galsky, Matthew D.
Afiliación
  • Bajorin DF; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Witjes JA; Radboud University, Nijmegen, the Netherlands.
  • Gschwend JE; Department of Urology, Technical University Munich, Munich, Germany.
  • Schenker M; Nectarie Oncology Center, Craiova, Romania.
  • Valderrama BP; Hospital Universitario Virgen del Rocío, Seville, Spain.
  • Tomita Y; Niigata University Graduate School of Medical & Dental Sciences, Niigata, Japan.
  • Bamias A; National & Kapodistrian University of Athens, Athens, Greece.
  • Lebret T; Urology Department, Hôpital Foch, Université Paris-Saclay, Université Versailles Saint-Quentin-en-Yvelines, Versailles, France.
  • Shariat SF; Weill Cornell Medical College New York, NY, USA.
  • Park SH; Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
  • Ye D; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Agerbaek M; Charles University, Prague, Czech Republic.
  • Enting D; Institute for Urology & Reproductive Health, IM Sechenov First Moscow State Medical University, Moscow, Russia.
  • McDermott R; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Gajate P; Fudan University Shanghai Cancer Center, Shanghai, China.
  • Peer A; Aarhus University Hospital, Aarhus, Denmark.
  • Milowsky MI; Guy's & St. Thomas' NHS Foundation Trust, London, UK.
  • Nosov A; St. Vincent's University Hospital & Cancer Trials Ireland, Dublin, Ireland.
  • Antonio JN; Ramon y Cajal University Hospital, Madrid, Spain.
  • Tupikowski K; Rambam Health Care Campus, Haifa, Israel.
  • Toms L; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Fischer BS; Federal State Budget Institution NN Petrov National Medical Research Center of Oncology of the Ministry of Health Care of the Russian Federation, St. Petersburg, Russia.
  • Qureshi A; Hospital de Amor de Barretos-Pio XII Foundation, Barretos, Brazil.
  • Collette S; Subdivision of Urology, Wroclaw Comprehensive Cancer Center, Wroclaw, Poland.
  • Unsal-Kacmaz K; Bristol Myers Squibb, Princeton, NJ, USA.
  • Broughton E; Bristol Myers Squibb, Princeton, NJ, USA.
  • Zardavas D; Bristol Myers Squibb, Princeton, NJ, USA.
  • Koon HB; Bristol Myers Squibb, Princeton, NJ, USA.
  • Galsky MD; Bristol Myers Squibb, Princeton, NJ, USA.
Future Oncol ; 19(6): 413-426, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36919916
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Neoplasias de los Músculos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Future Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Neoplasias de los Músculos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Future Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos